Roche utilizes Icagen in neuro drug discovery deal worth up to $274M
Roche and Icagen have agreed on a licensing and collaboration deal around ion channel modulators for neurological disorders. The duo did not disclose Roche’s upfront payment or research funding, but Icagen stands to receive up to $274 million in development and commercial milestones. The pair will work on small molecules using Icagen’s platform for ion